DD101672A5 - - Google Patents

Info

Publication number
DD101672A5
DD101672A5 DD167453A DD16745372A DD101672A5 DD 101672 A5 DD101672 A5 DD 101672A5 DD 167453 A DD167453 A DD 167453A DD 16745372 A DD16745372 A DD 16745372A DD 101672 A5 DD101672 A5 DD 101672A5
Authority
DD
German Democratic Republic
Application number
DD167453A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH1805171A external-priority patent/CH560715A5/de
Priority claimed from CH1805271A external-priority patent/CH560716A5/de
Application filed filed Critical
Publication of DD101672A5 publication Critical patent/DD101672A5/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • C07D457/06—Lysergic acid amides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DD167453A 1971-12-10 1972-12-08 DD101672A5 (en:Method)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH1805171A CH560715A5 (en) 1971-12-10 1971-12-10 N-substd lysergic acid amides - s saluretics and serotonin antagonists
CH1805271A CH560716A5 (en) 1971-12-10 1971-12-10 N-substd lysergic acid amides - s saluretics and serotonin antagonists

Publications (1)

Publication Number Publication Date
DD101672A5 true DD101672A5 (en:Method) 1973-11-12

Family

ID=25720424

Family Applications (1)

Application Number Title Priority Date Filing Date
DD167453A DD101672A5 (en:Method) 1971-12-10 1972-12-08

Country Status (17)

Country Link
JP (1) JPS4864099A (en:Method)
AT (1) AT339509B (en:Method)
BE (1) BE792515A (en:Method)
DD (1) DD101672A5 (en:Method)
DE (1) DE2259644A1 (en:Method)
ES (1) ES409461A1 (en:Method)
FI (1) FI53819C (en:Method)
FR (1) FR2162618B1 (en:Method)
GB (1) GB1410349A (en:Method)
HU (1) HU165738B (en:Method)
IE (1) IE38233B1 (en:Method)
IL (1) IL41035A (en:Method)
NL (1) NL7216464A (en:Method)
NO (1) NO135421C (en:Method)
PL (1) PL84879B1 (en:Method)
SE (1) SE398350B (en:Method)
SU (1) SU461500A3 (en:Method)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH653333A5 (de) * 1981-11-04 1985-12-31 Sandoz Ag N-substituierte ergolin- und 9,10-didehydroergolinderivate, ihre herstellung und sie enthaltende arzneimittel.
DE91652T1 (de) * 1982-04-13 1984-03-29 Farmitalia Carlo Erba S.p.A., 20159 Milano Ergolinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
US4563461A (en) * 1983-03-10 1986-01-07 Eli Lilly And Company Selective method for blocking 5HT2 receptors
KR20230024378A (ko) 2020-06-12 2023-02-20 벡클리 싸이테크 리미티드 5-메톡시-n, n-디메틸트립타민의 벤조에이트 염을 포함하는 조성물
WO2022153266A1 (en) 2021-01-15 2022-07-21 Beckley Psytech Limited Ergoline analogues
GB202212116D0 (en) 2022-08-19 2022-10-05 Beckley Psytech Ltd Pharmaceutically acceptable salts and Compositions thereof
US12264131B2 (en) 2022-08-19 2025-04-01 Beckley Psytech Limited Pharmaceutically acceptable salts and compositions thereof
US12246005B2 (en) 2023-06-13 2025-03-11 Beckley Psytech Limited 5-methoxy-n,n-dimethyltryptamine (5-MeO-DMT) formulations

Also Published As

Publication number Publication date
NL7216464A (en:Method) 1973-06-13
IE38233L (en) 1973-06-10
SU461500A3 (ru) 1975-02-25
IL41035A (en) 1975-08-31
SE398350B (sv) 1977-12-19
IL41035A0 (en) 1973-02-28
NO135421C (en:Method) 1977-04-05
AT339509B (de) 1977-10-25
FI53819C (fi) 1978-08-10
JPS4864099A (en:Method) 1973-09-05
HU165738B (en:Method) 1974-10-28
DE2259644A1 (de) 1973-06-14
PL84879B1 (en) 1976-04-30
GB1410349A (en) 1975-10-15
BE792515A (fr) 1973-06-08
ES409461A1 (es) 1976-04-01
FR2162618A1 (en:Method) 1973-07-20
FI53819B (fi) 1978-05-02
FR2162618B1 (en:Method) 1975-10-17
IE38233B1 (en) 1978-02-01
ATA1040772A (de) 1977-02-15
NO135421B (en:Method) 1976-12-27

Similar Documents

Publication Publication Date Title
FR2162618B1 (en:Method)
FR2153150A1 (en:Method)
CS154196B1 (en:Method)
CH246272A4 (en:Method)
BG20220A1 (en:Method)
CH578195A5 (en:Method)
BE786692A (en:Method)
CH560895A5 (en:Method)
CH577472A5 (en:Method)
BG17123A1 (en:Method)
BG17171A1 (en:Method)
CH1029372A4 (en:Method)
CH560559A5 (en:Method)
BG16941A1 (en:Method)
CH578630A5 (en:Method)
CH347171A4 (en:Method)
CH570410A5 (en:Method)
CH1231071A4 (en:Method)
BE788945A (en:Method)
CH577971A5 (en:Method)
CH554553A (en:Method)
CH579039A5 (en:Method)
CH562443A5 (en:Method)
CH559194A5 (en:Method)
CH567872A5 (en:Method)